Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Volar Fibroblast Injection Into the Stump Site of Amputees
NCT03947450Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Sep 2019
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Phase 2, randomised trial in skin wound (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Safety as assessed by number of hospitalizations at 12 months. Started Sep 2019; status: recruiting.
02
Conditions
skin wound
Beyond the preview
Go deeper on NCT03947450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03947450.